X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development FDA Approvals

EMA Given Aid To Support African Medicines Agency Setup

Content Team by Content Team
6th February 2024
in FDA Approvals, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The European Medicines Agency- EMA went on to announce on January 26, 2024, that the European Commission-EC has gone ahead and given the agency a €10 million grant in order to support regulatory systems at both the national as well as regional levels in Africa. The agreement has been inked by the EC’s directorate-general for international partnerships, thereby marking the project’s official launch. The African Medicines Agency- AMA treaty has gone on to be ratified by 27 countries, with more African Union- AU members likely to join.

EMA is going to collaborate with African, European, as well as international parties in order to set up the AMA, which is apparently going to be a specialized agency of that will be dedicated to improving access when it comes to safe and effective medical products across Africa. Experts are going to be mobilized by the EMA in order to support the AMA, technical committees, as well as regulators. Training will also be offered by the EMA in order to reinforce scientific as well as regulatory expertise.

In a press release from the EMA, it was stated that the creation of the AMA happens to be a unique opportunity in order to facilitate regulation as well as oversight of major medicines at the continental level, thereby promoting partnership among African countries and regions. By way of sharing its unique expertise as well as regulatory model, the EMRN- European medicines regulatory network will go ahead and share experience with AMA so as to pool-in resources as well as coordinate work in order to regulate medicines efficiently as well as effectively, thereby ensuring high-quality standards as well as the use of the best available expertise, thereby lessening the administrative burden in order to allow medicines to reach patients in a quick way and also accelerating the exchange of data when it comes to critical issues like medicine safety.

Executive Director of EMA, Emer Cooke, said in a press statement that the fact is that it will indeed be exciting to see AMA create its own regulatory model as well as practices in order to increase availability when it comes to safe and affordable medicines across Africa. EMA will go on to support this journey by way of sharing the learnings and also experiences gained by working together as a network of thousands of experts throughout Europe.

The head of the AMRH initiative at the African Union Development Agency-New Partnership for Africa’s Development, Chimwemwe Chamdimba, said that as African Medicines Regulatory Harmonisation- AMRH lays the foundation for AMA, their collaboration with EMA goes on to mark a crucial stride towards realization of the mission of AMA. Together, AMRH as well as EMA will speed up the establishment of AMA, thereby fostering greater partnership among African nations. This partnership not only signifies a shared commitment but, at the same time, also accelerates AMA’s journey of becoming a beacon when it comes to regulatory efficiency as well as healthcare advancement across Africa.

Previous Post

Possible Autoimmune Breakthrough With BCMA CAR T Therapy

Next Post

Guidance On CAR-T Cell Product Development Issued By FDA

Related Posts

WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Construction of WuXi Biologics Microbial Manufacturing Site
News

Construction of WuXi Biologics Microbial Manufacturing Site

19th June 2025
Beyfortus From Sanofi to Make Imprint in 2025 26 RSV Season
News

Beyfortus From Sanofi to Make Imprint in 2025-26 RSV Season

19th June 2025
Thermo-Fischer-Accelerator Drug Development an Ideal Choice
News

Thermo Fischer Accelerator Drug Development an Ideal Choice

19th June 2025
IQVIA Custom Built AI Agents for Life Sciences Healthcare
News

IQVIA Custom-Built AI Agents for Life Sciences, Healthcare

19th June 2025
SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Next Post

Guidance On CAR-T Cell Product Development Issued By FDA

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In